595 filings
Page 5 of 30
8-K
2912af
12 Dec 19
Regulation FD Disclosure
8:17am
8-K
zh9ue
5 Dec 19
Amendments to Articles of Incorporation or Bylaws
5:12pm
8-K
o03ri
19 Nov 19
Entry into a Material Definitive Agreement
7:00am
8-K
4hvdupw3h
12 Nov 19
Elite Pharmaceuticals, Inc. Reports Financial Results for the Second Quarter of Fiscal Year 2020
5:22pm
DEFA14A
a3q 9wf7urptp
18 Oct 19
Additional proxy soliciting materials
11:23am
8-K
obfy4r475m933 a4s
12 Sep 19
Elite Pharmaceuticals Receives FDA Approval for Codeine and Acetaminophen Combo
4:33pm
8-K
23dvh
9 Aug 19
Results of Operations and Financial Condition
4:52pm
8-K
yklngfos3zu
24 Jun 19
Results of Operations and Financial Condition
12:00am
NT 10-K
87cu18
14 Jun 19
Notice of late annual filing
12:59pm
8-K
wxn7x86
11 Mar 19
Elite Pharmaceuticals Enters into Strategic Marketing Alliance
4:02pm
8-K
6u1ngyigp53 s6t5
12 Feb 19
Elite Pharmaceuticals, Inc. Reports Financial Results for the Third Quarter of Fiscal Year 2019
12:00am
8-K
3rdh bwby7x8
3 Jan 19
Regulation FD Disclosure
3:56pm
8-K
no3c3dkd9s
10 Dec 18
Regulation FD Disclosure
4:00pm
8-K
ewrpa6ogpadb1217396
20 Nov 18
Elite Pharmaceuticals Receives FDA Approval for Hydrocodone and Acetaminophen Combo
4:05pm